Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment
This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment wa...
Gespeichert in:
Veröffentlicht in: | Alzheimer disease and associated disorders 2011-07, Vol.25 (3), p.250-261 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 261 |
---|---|
container_issue | 3 |
container_start_page | 250 |
container_title | Alzheimer disease and associated disorders |
container_volume | 25 |
creator | FRANK, Gabriele HENNIG-FAST, Kristina KLÜNEMANN, Hans H SCHMITZ, Gerd GREENLEE, Mark W |
description | This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms. |
doi_str_mv | 10.1097/WAD.0b013e3182061636 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885296584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>885296584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c251t-650ce86486449f5d16887525cc93aacb8aca006e051d1cb1a92790f734e98a6b3</originalsourceid><addsrcrecordid>eNpdUctq3DAUFSUlmTz-oBRtSlZOr6yHpaWZyWMgJaE0ZGlkWU5VbHkq2QP5p2zzG_mmaCbTBgKCi-49jysdhL4QOCOgiu_35eIMaiDUUiJzEERQ8QnNCGciY4SLPTQDqWgGlJEDdBjjHwAoKId9dJATovKc8hl6Wri2tcH60ekOL_uVNiMeWlyuhnP88szw4PF8CKMzaVya0a316FJvMQXnH_CF7ocppmIs_mnN8ODdduw2rO1lbbtHvPTjRnfpG7d2zaS7iLVv8G3SSs4R37vxNy57b2Mywj9c17zTt0u50CfgMfrcJq492dUjdHdx_mt-lV3fXC7n5XVmck7GTHAwVgqWDlMtb4iQsuA5N0ZRrU0ttdEAwgInDTE10SovFLQFZVZJLWp6hE7fdFdh-DulpareRWO7TnubnltJyXMluGQJyd6QJgwxBttWq-B6HR4rAtUmpirFVH2MKdG-7gymurfNf9K_XBLg2w6gY_r5NmhvXHzHMQ5cSEFfAUZYngE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885296584</pqid></control><display><type>article</type><title>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>FRANK, Gabriele ; HENNIG-FAST, Kristina ; KLÜNEMANN, Hans H ; SCHMITZ, Gerd ; GREENLEE, Mark W</creator><creatorcontrib>FRANK, Gabriele ; HENNIG-FAST, Kristina ; KLÜNEMANN, Hans H ; SCHMITZ, Gerd ; GREENLEE, Mark W</creatorcontrib><description>This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.</description><identifier>ISSN: 0893-0341</identifier><identifier>EISSN: 1546-4156</identifier><identifier>DOI: 10.1097/WAD.0b013e3182061636</identifier><identifier>PMID: 21192235</identifier><identifier>CODEN: ADADE2</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Amnesia - genetics ; Apolipoprotein E4 - genetics ; Biological and medical sciences ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - genetics ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Female ; Genetic Predisposition to Disease - genetics ; Genotype ; Humans ; Image Interpretation, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Memory Disorders - genetics ; Middle Aged ; Neurology ; Neuropharmacology ; Neuropsychological Tests ; Pattern Recognition, Visual - physiology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Recognition (Psychology) - physiology</subject><ispartof>Alzheimer disease and associated disorders, 2011-07, Vol.25 (3), p.250-261</ispartof><rights>2015 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c251t-650ce86486449f5d16887525cc93aacb8aca006e051d1cb1a92790f734e98a6b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24505686$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21192235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FRANK, Gabriele</creatorcontrib><creatorcontrib>HENNIG-FAST, Kristina</creatorcontrib><creatorcontrib>KLÜNEMANN, Hans H</creatorcontrib><creatorcontrib>SCHMITZ, Gerd</creatorcontrib><creatorcontrib>GREENLEE, Mark W</creatorcontrib><title>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</title><title>Alzheimer disease and associated disorders</title><addtitle>Alzheimer Dis Assoc Disord</addtitle><description>This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.</description><subject>Amnesia - genetics</subject><subject>Apolipoprotein E4 - genetics</subject><subject>Biological and medical sciences</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - genetics</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Female</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory Disorders - genetics</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuropsychological Tests</subject><subject>Pattern Recognition, Visual - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Recognition (Psychology) - physiology</subject><issn>0893-0341</issn><issn>1546-4156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUctq3DAUFSUlmTz-oBRtSlZOr6yHpaWZyWMgJaE0ZGlkWU5VbHkq2QP5p2zzG_mmaCbTBgKCi-49jysdhL4QOCOgiu_35eIMaiDUUiJzEERQ8QnNCGciY4SLPTQDqWgGlJEDdBjjHwAoKId9dJATovKc8hl6Wri2tcH60ekOL_uVNiMeWlyuhnP88szw4PF8CKMzaVya0a316FJvMQXnH_CF7ocppmIs_mnN8ODdduw2rO1lbbtHvPTjRnfpG7d2zaS7iLVv8G3SSs4R37vxNy57b2Mywj9c17zTt0u50CfgMfrcJq492dUjdHdx_mt-lV3fXC7n5XVmck7GTHAwVgqWDlMtb4iQsuA5N0ZRrU0ttdEAwgInDTE10SovFLQFZVZJLWp6hE7fdFdh-DulpareRWO7TnubnltJyXMluGQJyd6QJgwxBttWq-B6HR4rAtUmpirFVH2MKdG-7gymurfNf9K_XBLg2w6gY_r5NmhvXHzHMQ5cSEFfAUZYngE</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>FRANK, Gabriele</creator><creator>HENNIG-FAST, Kristina</creator><creator>KLÜNEMANN, Hans H</creator><creator>SCHMITZ, Gerd</creator><creator>GREENLEE, Mark W</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201107</creationdate><title>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</title><author>FRANK, Gabriele ; HENNIG-FAST, Kristina ; KLÜNEMANN, Hans H ; SCHMITZ, Gerd ; GREENLEE, Mark W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c251t-650ce86486449f5d16887525cc93aacb8aca006e051d1cb1a92790f734e98a6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Amnesia - genetics</topic><topic>Apolipoprotein E4 - genetics</topic><topic>Biological and medical sciences</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - genetics</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Female</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory Disorders - genetics</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuropsychological Tests</topic><topic>Pattern Recognition, Visual - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Recognition (Psychology) - physiology</topic><toplevel>online_resources</toplevel><creatorcontrib>FRANK, Gabriele</creatorcontrib><creatorcontrib>HENNIG-FAST, Kristina</creatorcontrib><creatorcontrib>KLÜNEMANN, Hans H</creatorcontrib><creatorcontrib>SCHMITZ, Gerd</creatorcontrib><creatorcontrib>GREENLEE, Mark W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Alzheimer disease and associated disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FRANK, Gabriele</au><au>HENNIG-FAST, Kristina</au><au>KLÜNEMANN, Hans H</au><au>SCHMITZ, Gerd</au><au>GREENLEE, Mark W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment</atitle><jtitle>Alzheimer disease and associated disorders</jtitle><addtitle>Alzheimer Dis Assoc Disord</addtitle><date>2011-07</date><risdate>2011</risdate><volume>25</volume><issue>3</issue><spage>250</spage><epage>261</epage><pages>250-261</pages><issn>0893-0341</issn><eissn>1546-4156</eissn><coden>ADADE2</coden><abstract>This study explores the neurofunctional correlates of the recognition of famous faces in patients with amnestic mild cognitive impairment (aMCI) and healthy controls depending on the genetic risk factor, Apolipoprotein E (ApoE) ε4. An event-related functional magnetic resonance imaging experiment was conducted while participants discriminated between famous and nonfamous faces. We compared the results of 32 healthy controls [17 ApoE ε4 carriers (E4+); 15 noncarriers (E4-)] with those of 30 patients with aMCI (16 E4+; 14 E4-). Despite comparable task performance, patients with aMCI, E4+ showed significantly less activation in a large cortical network including the left parahippocampal gyrus than patients with aMCI E4-. Furthermore, in the aMCI group, we found significantly reduced activation in the left parahippocampal gyrus and posterior cingulate cortex compared with the control group. Our results show that critical regions of the brain show functional decline associated with major risk factors, such as ApoE ε4 allele and neuropsychological signs of aMCI for the development of Alzheimer disease. Importantly, the ApoE genotype seems to influence cortical activation in patients with aMCI and to a lesser degree in healthy controls as well, who are without any cognitive symptoms.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>21192235</pmid><doi>10.1097/WAD.0b013e3182061636</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-0341 |
ispartof | Alzheimer disease and associated disorders, 2011-07, Vol.25 (3), p.250-261 |
issn | 0893-0341 1546-4156 |
language | eng |
recordid | cdi_proquest_miscellaneous_885296584 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Amnesia - genetics Apolipoprotein E4 - genetics Biological and medical sciences Cognitive Dysfunction - diagnosis Cognitive Dysfunction - genetics Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Female Genetic Predisposition to Disease - genetics Genotype Humans Image Interpretation, Computer-Assisted Magnetic Resonance Imaging Male Medical sciences Memory Disorders - genetics Middle Aged Neurology Neuropharmacology Neuropsychological Tests Pattern Recognition, Visual - physiology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Recognition (Psychology) - physiology |
title | Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T23%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Impact%20of%20ApoE%20%CE%B54%20on%20Cortical%20Activation%20During%20Famous%20Face%20Recognition%20in%20Cognitively%20Intact%20Individuals%20and%20Patients%20With%20Amnestic%20Mild%20Cognitive%20Impairment&rft.jtitle=Alzheimer%20disease%20and%20associated%20disorders&rft.au=FRANK,%20Gabriele&rft.date=2011-07&rft.volume=25&rft.issue=3&rft.spage=250&rft.epage=261&rft.pages=250-261&rft.issn=0893-0341&rft.eissn=1546-4156&rft.coden=ADADE2&rft_id=info:doi/10.1097/WAD.0b013e3182061636&rft_dat=%3Cproquest_cross%3E885296584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885296584&rft_id=info:pmid/21192235&rfr_iscdi=true |